Clinical trial
The Impact of Perinatal Daily Supplement of a Probiotic (Lactobacillus Rhamnosus GG), Given to Mothers, on Immunological Development, Atopic Sensitisation and Allergic Disease in Their Off-spring
NCT00159523 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Perinatal Daily Supplement of a Probiotic (Lactobacillus Rhamnosus GG), Given to Mothers, on Immunological Development, Atopic Sensitisation and Allergic Disease in Their Off-spring
- Lead sponsor
- Norwegian University of Science and Technology
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2003
- Completion date
- September 30, 2007
- Enrollment
- 416 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.